RVNC

Revance Therapeutics (RVNC)

Revance Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RVNC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/29	05:05	Business Wire	Revance to Participate in Upcoming Investor Conferences	NASDAQ:RVNC	Revance Therapeutics Inc
2024/05/10	05:33	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RVNC	Revance Therapeutics Inc
2024/05/10	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVNC	Revance Therapeutics Inc
2024/05/10	05:06	Business Wire	Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update	NASDAQ:RVNC	Revance Therapeutics Inc
2024/05/10	05:05	Business Wire	Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia	NASDAQ:RVNC	Revance Therapeutics Inc
2024/05/03	05:05	Business Wire	Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024	NASDAQ:RVNC	Revance Therapeutics Inc
2024/04/12	21:00	Business Wire	Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/28	05:05	Business Wire	Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/09	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/06	07:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/06	07:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/05	07:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/05	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/05	06:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/05	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/04	23:25	Business Wire	Revance Announces Pricing of $100.0 Million Public Offering of Common Stock	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/04	20:39	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/04	20:37	Business Wire	Revance Announces Proposed Public Offering of Common Stock	NASDAQ:RVNC	Revance Therapeutics Inc
2024/03/01	06:36	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/29	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/29	06:05	Business Wire	Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/21	22:01	Business Wire	Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/21	22:00	Business Wire	Revance to Participate in Upcoming Investor Conferences	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/15	05:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/14	06:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/13	23:39	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/07	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/03	06:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/03	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc
2024/02/03	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVNC	Revance Therapeutics Inc